NCT05890313 · NOT YET RECRUITING

Improving the Referral of Patients With Suspected Cognitive Impairment and Early Dementia

This trial is testing whether two cognitive screening tools — the paper-based MMSE and MoCA tests, and a web-based digital tool called Brain on Track — help primary care doctors in Portugal make better decisions about referring patients with suspected memory problems to neurology specialists. It is a Phase NA (not a drug trial — this is a care-process study) comparing these structured screening approaches against standard clinical practice.

You may qualify if

  • Adults who are native from Portugal and fluent in Portuguese, have not already been diagnosed with dementia, have no motor, visual and/or hearing limitations and present to PCCs with cognitive complaints
  • In group Brain on Track/MoCA/MMSE, related to Brain on Track: have a computer and/or tablet at home, with internet access, and have minimal computer literacy, in addition to the previous referred inclusion criteria

You're excluded if

  • Motor, visual and hearing limitations

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-01-25

View full record on ClinicalTrials.gov

All APOE4 clinical trials